Ultralife Corp. (ULBI) Income Statement

Click line-items for a historical chart and %

Revenues
Cost of products sold
Gross margin	6M
Research and development (including $79, $95, $157 and $219, respectively, of amortization of intangible assets)	1.36M
Selling, general, and administrative (including $78, $80, $157 and $247, respectively, of amortization of intangible assets)	3.5M
Total operating expenses	4.86M
Operating income (loss)	1.14M
Interest income
Interest expense
Miscellaneous	20K
Income (loss) from continuing operations before income taxes
Income tax provision-current
Income tax provision-deferred
Total income taxes	92K
Net income (loss) from continuing operations
Loss from discontinued operations, net of tax
Net income (loss)	1.02M
Net (income) loss attributable to noncontrolling interest	3K
Net income (loss) attributable to Ultralife	1.02M
Continuing operations
Discontinued operations
Total	0.07
Continuing operations
Discontinued operations
Total	0.07
Weighted average shares outstanding - basic	15.21M
Weighted average shares outstanding - diluted	15.3M

Entities mentioned with ULBI

View All Entities